Scholarlink

Background <p>Eucalyptol (1,8-cineole), a naturally occurring monoterpenoid compound, is ubiquitously distributed across plant, animal, and microbial organisms. This bioactive molecule demonstrates significant therapeutic potential for various neurological and respiratory disorders, including cancer, epilepsy, and tracheitis, attributable to its potent antioxidant, anti-inflammatory, and antimicrobial properties.</p> Scope and thrust <p>The present review systematically examines the biosynthetic pathways and metabolic routes of eucalyptol, while elucidating its molecular mechanisms underlying microbial inhibition. We comprehensively summarize its principal therapeutic pathways in major disease interventions, with particular emphasis on its multi-target pharmacological actions. Furthermore, this analysis addresses potential toxicological concerns associated with eucalyptol application and discusses emerging strategies utilizing biological agents for active enhancement.</p> Conclusion and significance <p>This comprehensive evaluation not only enhances our understanding of eucalyptol’s therapeutic mechanisms but also provides critical insights for its development as a promising phytopharmaceutical agent in clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The comprehensive review of eucalyptol: synthesis, metabolism, and therapeutic applications in disease treatment

  • 期刊论文

  • 发表日期：

    2025年3月28日

查看全文
  • Bin Yao,
  • Bin He,
  • Jiahua Peng,
  • Xin Song,
  • Rui Zhao,
  • Yu Sun,
  • Yanfang Zhang

摘要

Background

Eucalyptol (1,8-cineole), a naturally occurring monoterpenoid compound, is ubiquitously distributed across plant, animal, and microbial organisms. This bioactive molecule demonstrates significant therapeutic potential for various neurological and respiratory disorders, including cancer, epilepsy, and tracheitis, attributable to its potent antioxidant, anti-inflammatory, and antimicrobial properties.

Scope and thrust

The present review systematically examines the biosynthetic pathways and metabolic routes of eucalyptol, while elucidating its molecular mechanisms underlying microbial inhibition. We comprehensively summarize its principal therapeutic pathways in major disease interventions, with particular emphasis on its multi-target pharmacological actions. Furthermore, this analysis addresses potential toxicological concerns associated with eucalyptol application and discusses emerging strategies utilizing biological agents for active enhancement.

Conclusion and significance

This comprehensive evaluation not only enhances our understanding of eucalyptol’s therapeutic mechanisms but also provides critical insights for its development as a promising phytopharmaceutical agent in clinical practice.